期刊文献+

RP-HPLC法测定吉非替尼分散片的含量 被引量:2

Content Determination of Gefitinib Dispersible Tablets by RP-HPLC
原文传递
导出
摘要 目的:建立测定吉非替尼分散片中主药含量的方法。方法:采用反相高效液相色谱法。色谱柱为Diamonsil C18(2),流动相为乙腈-0.015%三氟乙酸(26:74,三乙胺调pH值为3.9),流速为1.0mL.min-1,检测波长为344nm,柱温为30℃。结果:吉非替尼检测浓度线性范围为0.08~6.05μg.mL-1(r=0.9998);平均回收率为100.55%,RSD=1.28%(n=9)。结论:该方法操作简便、快速、重复性好,可用于吉非替尼分散片的含量测定。 OBJECTIVE: To establish the method for the content determination of main component in Gefitinib dispersible tablet. METHODS: RP-HPLC method was adopted. The separation was achieved by Diamonsil C18 (2) column using acetoni- trile-0.015% trifluoroacetic acid (26:74, pH adjusted to 3.9 with triethanolamine) as mobile phase at the flow rate of 1.0 mL.min-t. The detection wavelength was set at 344 nm and the column temperature was 30 ℃. RESULTS: The linear range of gefitinib was 0.08-6.05 μg.mL-1 (r=0.999 8) with an average recovery of 100.55% (RSD=1.28%, n=9). CONCLUSION: The method is simple, rapid and reproducible, and it is suitable for the content determination in Gefitinib dispersible tablet.
出处 《中国药房》 CAS CSCD 2012年第13期1225-1226,共2页 China Pharmacy
关键词 吉非替尼分散片 反相高效液相色谱法 含量测定 Gefitinib dispersible tablet RP-HPLC Content determination
  • 相关文献

参考文献4

二级参考文献17

  • 1杨玲,李连弟,陈育德,Donald Maxwell Parkin.中国肺癌死亡趋势分析及发病、死亡的估计与预测[J].中国肺癌杂志,2005,8(4):274-278. 被引量:167
  • 2胡培安,孙怡芬,仝丽,李宝兰,傅瑜.吉非替尼治疗晚期非小细胞肺癌三例报告[J].北京医学,2005,27(10):634-634. 被引量:2
  • 3黄莹莹,伍建宇,程刚.吉非替尼致麻痹性肠梗阻[J].药物不良反应杂志,2006,8(6):450-451. 被引量:6
  • 4Schiller JH.New direactions for ZD1839 in the treatment of solid tumors[J].Semin Oncol, 2003,30 ( Suppl 1 ) : 49.
  • 5Dudek AZ, Knak KL, Koopmeiners J, et al.Skin rash and bronchoalveolar histolgy correlates with clinical benefit in patients treated with gefitinib as therapy for previously treated advanced or metastatic non-small cell lung cancer [J].Lung Cancer Jan, 2006,51 ( 1 ) : 89.
  • 6Okamoto I, Fujii K, Matsumoto M, et al.Diffuse alveolar damage after ZD1839 therapy in a patient with nonsmaU cell lun cancer[J].Lun Cancer, 2003,40 ( 3 ) : 339.
  • 7International agency for research on Cancer. Worm Cancer Report 2008[R]. 390-391.
  • 8Parkin DM, Bray F, Ferlay J, etal. Estimating the world cancer burden: Globocan 2000[J]. lnt J Cancer, 2001, 94 (2) : 153.
  • 9中国网.卫生部召开发布会介绍第3次全国死因调查主要情况[EB/OL].http://www.china.com.cn/zhibo/2008-04/29/content_15028586.htm.2008-04-29.2010-05-30.
  • 10Novello S, Le Chevalier T.Chemotherapy for non-small- cell lung cancer. Part 1 : early stage disease[J]. Oncology, 2003,17(3) : 357.

共引文献33

同被引文献14

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部